Northwind_Logo_Color_CS3Northwind Pharmaceuticals provides pharmaceuticals to clinics for in-office dispensing.  Founded in 1981, Northwind Pharmaceuticals offers a variety of products to physicians interested in providing medication dispensing services to patients.

Here is a summary of our offerings:

  • Prepackaged pharmaceuticals – bulk product repackaged into unit-of-use sizes for physician dispensing.
  • Injectables
  • Lotion, cream, ointments
  • Liquids
  • Medical Supplies

You can view a complete list of our pharmaceuticals and medical supplies in our online catalog.

Northwind offers two dispensing systems to clinics interested in pharmaceutical dispensing.  Our manual system uses carbon labels to capture patient information and medication instructions.  The labels are kept in a logbook for accurate record keeping.  We also offer MD Scripts, a web-based system which allows clinics to track inventory, print patient labels and reorder electronically.  Both systems are offered at no-charge to Northwind customers.

For more information, please visit us at www.nwpharma.com.  You can also call us at 800.722.0772 or email info@nwpharma.com.

 

Schedule a free claims analysis now.

Let’s Talk now

Leader in AI-driven health benefits navigation Healthee partners with Northwind

Katherine Lurk | Mar 28th, 2025
A game-changer for employers looking to cut costs and gain control With healthcare costs continuing to rise, employers are seeking new ways to rein in spending without sacrificing the quality of benefits. This partnership enables Healthee clients to optimize prescription drug management, reducing costs through preferable generic drug pricing, high-touch chronic care programs, and more. … more »

continue reading

Healthcare Storm 2025: What Will It Be?

Phillip Berry | Jan 1st, 2025
When it comes to American healthcare, we’ve become really good at highlighting its failings. Watching the flurry of lamentations, frustrations, denigrations, and prognostications, over the last few weeks, would lead any rational person to believe that nothing is working in our healthcare system. And, not only is it “not working,” many people conclude that it … more »

continue reading

New Drugs to Market – October Update

Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies,  Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »

continue reading